Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medsol RX vs ShedRx

Medsol RX
Site position #236

Lower grade

vs+21.2
ShedRx
Site position #3

Higher grade

The verdict

ShedRx takes it — 87/100 to 65.8/100.

ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueShedRx +39
45
84
Dose & formulationShedRx +8
88
96
Clinical oversightShedRx +5
79
84
Labs & monitoringShedRx +31
53
84
FulfillmentShedRx +5
83
88
Contract termsShedRx +44
41
85
Medsol RX · left barShedRx · right bar

The numbers

MetricMedsol RXShedRx
WeighScore65.8/10087/100
GradeCB+
Site position#236#3
SemaglutideFrom $169/mo advertised; package prices differ$199/mo
TirzepatideFrom $239/mo advertised; confirm selected plan$299/mo
CoverageNationwide claimed; confirm treatment eligibilityAll 50 states
Brand-name accessYesYes
Oral / sublingualYesYes
Medsol RX

Site position #236 · C

Strengths

  • Current menu includes compounded injections, oral semaglutide and branded pens
  • Describes dedicated coaching and OpenLoop clinician review

Where it loses points

  • Standalone starting prices differ from the separate three-, six- and twelve-month package panel
  • Final drug, dose, charge and renewal quote must be confirmed
ShedRx

Site position #3 · B+

Strengths

  • Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
  • Brand Zepbound and Wegovy available beside the compounded line
  • Health coaching included with membership, plus a published 120-day weight-loss guarantee

Where it loses points

  • The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
  • The dispensing compounding pharmacy is not publicly named

Featured provider

ShedRx

ShedRx scores 87/100 (B+). The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard